ArticleScience progress

SMARCB1/INI-1-Deficient sinonasal carcinoma demonstrates a poor prognosis but favorable clinical outcomes after PD-1/PD-L1 inhibitor therapy: A case series.

Shuhan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.